Clinical Investigative Site 002 — Oklahoma City, Oklahoma

Clinical Investigative Site 002 is a clinical research site located in Oklahoma City, Oklahoma, United States 73112.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Investigative Site 002 has participated in 1 clinical trials.

Therapeutic areas: Renal Failure, Tremors.

Sponsors: Veloxis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Investigative Site 002?

Clinical Investigative Site 002 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Investigative Site 002 conducted?

Clinical Investigative Site 002 has 1 clinical trials on record. Their work covers Renal Failure, Tremors.

Is Clinical Investigative Site 002 accredited by Crixeo Health?

Clinical Investigative Site 002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Investigative Site 002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.